Revelation Biosciences, Inc.

Historical 13F Holders

Symbol
REVB
CUSIP
76135L101
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 76135L101 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Sabby Management, LLC 13G/A
4.9% 1/2/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 1 0 $0
2025 Q1 1 0 $0
2024 Q4 1 0 $0
2024 Q3 1 0 $0
2024 Q2 1 0 $0
2024 Q1 1 0 $0
2023 Q4 1 0 $0
2023 Q3 1 0 $0
2023 Q2 1 0 $0
2023 Q1 1 0 $0
2022 Q4 12 2.35 M $448 k
2022 Q3 15 2.25 M $589 k
2022 Q2 13 3.22 M $3.57 M
2022 Q1 17 3.02 M $3.44 M
2021 Q4 2 64.3 k $657 k